Αρχική World News Radiation Treatment Delivery Improved Using a Visualization of the Invisible Radiation Beam

Radiation Treatment Delivery Improved Using a Visualization of the Invisible Radiation Beam

When a cancer patient is undergoing radiation treatment, neither she nor the radiation therapist providing the treatment can see the actual beam of radiation. Once the patient is properly marked and positioned for treatment, it’s impossible to see whether the invisible beam continues to hit the right spot throughout the session.

Of course, radiation therapists are careful to make sure the area being treated is perfectly lined up so that the treatment is effective and the radiation doesn’t harm any healthy cells outside of the treatment area. However, if the patient moves during treatment or if the equipment somehow slips from its original position, the radiation treatment may not work the way it is supposed to, and unexpected areas of the skin may be affected.

Photo: Adobe Stock/Mark Kostich

Thanks to a system called Cherenkov imaging, however, some cancer patients are getting a better experience than they used to. Cherenkov imaging provides a visual representation of the invisible beam of radiation, allowing the patient and the therapist to see exactly where the radiation is being directed in real time. In this way, the beam can be constantly monitored for accidental shifting and repositioned as necessary.

The system works by capturing light emissions during radiotherapy and creating a visual image on the skin’s surface in the exact shape of the area being targeted by radiation beams. The system ensures that every single linac pulse contributes to the image in real time, and the intensity of the light generated by the system is in direct proportion to the dose being delivered.

Photo: Adobe Stock/Mark Kostich

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

At the Dartmouth-Hitchcock Medical Center, the Cherenkov imaging system is being used to give patients a better outcome after radiation therapy. The team there, led by Lesley Jarvis, conducted a study examining the usefulness of Cherenkov imaging in clinical practice.

“In this limited cohort, we found opportunities to improve treatment delivery for individual patients,” write the authors. “Of specific clinical importance, we show that Cherenkov imaging can detect stray radiation dose to tissues. Currently, there is no practical technique available to monitor contralateral breast dose or dose to other adjacent anatomy on a daily basis.”

The team studied 64 patients undergoing radiation therapy for breast cancer (29), sarcoma/lymphomas (23), and other cancers, using techniques including 3D conformal radiotherapy, total skin electron therapy, arc therapy, and total body irradiation. The team used the system’s automated image analysis software to determine that the Cherenkov emissions matched the expected distribution that had been predicted.

Photo: Adobe Stock/Mark Kostich

“Typical ROIs (regions of interest) for optical surface imaging systems are often focused on a small area and do not detect alignment issues outside of the ROI,” write the researchers. “This may have the consequence of giving the clinical team a false sense of security.”

The team is now planning a large retrospective analysis of clinical data from patients receiving radiation therapy at Dartmouth-Hitchcock to further investigate the benefits of Cherenkov imaging.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Making Important Decisions During Cancer: A Survivor’s Story

Bethany Hart lives with her husband Kevin, sons, and 3 dogs in the suburbs of Indianapolis, Indiana. She is a survivor of small cell neuroendocrine cervical cancer....

Adjuvant Immunotherapy Approved for Some Patients with Lung Cancer

October 26, 2021, by NCI Staff Atezolizumab (Tecentriq) is approved as an additional treatment for some patients with stage II to IIIA (pictured) non-small cell...

Cure Probability Models for Evaluation of Patients with a Previous Cancer Diagnosis for Solid Organ Transplantation

Findings from a first study that applied a formal statistical framework to inform the evaluation of transplant candidates with a previous cancer diagnosis were...

Teacher Reads To Students One Day After Having Brain Surgery

Meucci - who had her surgery on a Wednesday - was going live from her intensive care unit hospital room that very next Thursday...

6 things you need to know about cervical screening

This article was originally published in 2017 during Cervical Screening Awareness Week. It has now been reviewed and updated. Cervical screening, also known as the...

EMA Recommends Granting a Marketing Authorisation for Sacituzumab Govitecan

On 14 October 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...